Products
16523 Results
Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
American Express Constant Leverage with ISIN code: CH1119067606 | American Express | Constant Leverage | Long | ― | 266.811 | 6.95 | 0.030 | 6.98 | 1 | -0.57% | 8.42% | -31.59% | 10 May. 2022 | |
American Express Constant Leverage with ISIN code: CH1345999283 | American Express | Constant Leverage | Short | ― | 266.811 | 0.2 | 0.020 | 0.22 | 1 | -9.09% | -20.00% | -97.82% | 18 Apr. 2024 | |
American Express Constant Leverage with ISIN code: CH1362351210 | American Express | Constant Leverage | Short | ― | 266.811 | 4.07 | 0.020 | 4.09 | 1 | 0.00% | -11.14% | -52.00% | 30 Sep. 2024 | |
Amgen Constant Leverage with ISIN code: CH1119067564 | Amgen | Constant Leverage | Long | ― | 291.007 | 4.12 | 0.030 | 4.15 | 1 | 1.73% | 16.71% | -59.69% | 10 May. 2022 | |
Amgen Constant Leverage with ISIN code: CH1197222883 | Amgen | Constant Leverage | Long | ― | 291.007 | 1.03 | 0.020 | 1.05 | 1 | 1.98% | 25.61% | -90.06% | 23 Jun. 2022 | |
Amgen Constant Leverage with ISIN code: CH1396329000 | Amgen | Constant Leverage | Long | ― | 291.007 | 3.84 | 0.060 | 3.9 | 1 | 3.78% | 35.69% | -56.41% | 12 Feb. 2025 | |
Amgen Constant Leverage with ISIN code: CH1119067572 | Amgen | Constant Leverage | Short | ― | 291.007 | 0.66 | 0.020 | 0.68 | 1 | -4.35% | -18.52% | -93.22% | 10 May. 2022 | |
Amgen Constant Leverage with ISIN code: CH1345999275 | Amgen | Constant Leverage | Short | ― | 291.007 | 0.3 | 0.020 | 0.32 | 1 | -9.09% | -26.83% | -96.82% | 18 Apr. 2024 | |
Apple Constant Leverage with ISIN code: CH1396328176 | Apple | Constant Leverage | Long | ― | 210.452 | 0.071 | 0.002 | 0.073 | 1 | -6.58% | 22.41% | -99.34% | 12 Feb. 2025 | |
Apple Constant Leverage with ISIN code: CH1197222834 | Apple | Constant Leverage | Long | ― | 210.452 | 1.21 | 0.020 | 1.23 | 1 | -3.97% | 13.08% | -88.87% | 23 Jun. 2022 | |
Apple Constant Leverage with ISIN code: CH1290993885 | Apple | Constant Leverage | Long | ― | 210.452 | 0.01 | ― | ― | 1 | 0.00% | 0.00% | -99.88% | 18 Apr. 2024 | |
Apple Constant Leverage with ISIN code: CH1119067549 | Apple | Constant Leverage | Long | ― | 210.452 | 3.23 | 0.020 | 3.25 | 1 | -2.12% | 9.49% | -69.53% | 10 May. 2022 | |
Apple Constant Leverage with ISIN code: CH1197222842 | Apple | Constant Leverage | Long | ― | 210.452 | 0.086 | 0.002 | 0.088 | 1 | -4.44% | 16.22% | -99.24% | 23 Jun. 2022 | |
Apple Constant Leverage with ISIN code: CH1396329232 | Apple | Constant Leverage | Long | ― | 210.452 | 0.01 | 0.002 | 0.012 | 1 | -16.67% | 11.11% | -99.81% | 13 Mar. 2025 | |
Apple Constant Leverage with ISIN code: CH1119067556 | Apple | Constant Leverage | Short | ― | 210.452 | 0.21 | 0.020 | 0.23 | 1 | -4.55% | -12.50% | -97.75% | 10 May. 2022 | |
Apple Constant Leverage with ISIN code: CH1346000156 | Apple | Constant Leverage | Short | ― | 210.452 | 0.8 | 0.020 | 0.82 | 1 | 1.27% | -17.53% | -90.91% | 9 Jul. 2024 | |
Apple Constant Leverage with ISIN code: CH1362351699 | Apple | Constant Leverage | Short | ― | 210.452 | 0.027 | 0.002 | 0.029 | 1 | -3.57% | -27.03% | -99.64% | 3 Dec. 2024 | |
Apple Constant Leverage with ISIN code: CH1362351707 | Apple | Constant Leverage | Short | ― | 210.452 | 0.08 | 0.002 | 0.082 | 1 | 1.27% | -27.27% | -98.97% | 3 Dec. 2024 | |
Apple Constant Leverage with ISIN code: CH1362351582 | Apple | Constant Leverage | Short | ― | 210.452 | 0.083 | 0.002 | 0.085 | 1 | 1.22% | -24.55% | -99.06% | 27 Nov. 2024 | |
Apple Constant Leverage with ISIN code: CH1119065998 | Apple | Constant Leverage | Short | ― | 210.452 | 0.11 | 0.010 | 0.12 | 1 | 0.00% | -21.43% | -98.80% | 1 Oct. 2021 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.